IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Peer Comparison
Performance
Performance Report
IPO Review
IPO Review
Aptus Pharma IPO listing price is ₹ 80.80, issue price is ₹ 70.00, and currently trading at ₹ 88.32 as on October 8, 2025. Aptus Pharma IPO performance is show below with latest CAGR.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Aptus Pharma IPO is a Book Building listing on BSE SME exchange. The company is based in Ahmedabad and caters to Pharmaceutical sector. Interactive Financial Services is the merchant banker of Aptus Pharma IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 18th June 2025.
Aptus Pharma IPO offer price is ₹ 70.00 and got listed at ₹ 80.80. Read Aptus Pharma IPO details mentioned above.The IPO of Aptus Pharma Limited was listed on 30th September 2025. As of today, Aptus Pharma IPO is trading at ₹ 88.32, compared to the previous day’s close of ₹ 85.90. Read the report above for detailed IPO performance.
The issue price of Aptus Pharma IPO was ₹ 70.00 per equity share.
Aptus Pharma IPO was listed at ₹80.80 on the stock exchange on 30th September 2025. The listing price is the price at which the shares started trading on the stock exchange after the IPO was completed.
As of October 8, 2025, the current market price of Aptus Pharma IPO is ₹ 88.32.
The 52-week high for Aptus Pharma IPO is ₹ 89.00, while the 52-week low is ₹ 80.80. These figures reflect the stock’s highest and lowest trading prices in the past one year from the current date.
The Aptus Pharma IPO listed at ₹ 80.80 against the issue price of ₹ 70.00 per equity share, showing a listing day gain/loss of 10.8 (15.43%) , calculated by comparing the listing price to the issue price on the first day of trading.
The Aptus Pharma IPO stock moved from its listing price of ₹ 80.80 to the current price of ₹88.32 per equity share, reflecting a change of 9.31% per share, calculated by subtracting the listing price from the current market price (CMP) as of today.
Based on Aptus Pharma IPO issue date of 30th September 2025 and CMP of ₹88.32, the estimated CAGR is approximately 1243069.28%.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Face
Value :
₹ 10
Issue
Price :
₹ 70.00
Listing Price :
₹ 80.80
Previous Day Closing
₹ 85.90
Aptus Pharma IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Aptus Pharma Financial Review Page
Merchant Banker(s) of Aptus Pharma IPO: Interactive Financial Services Limited
Aptus Pharma IPO subscription was 22.27 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Aptus Pharma IPO listed at a listing price of 80.80 against the offer price of 70.00.
The current market price of Aptus Pharma is 88.32.
Why Us?
